Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity

被引:36
作者
Smith, MBK
Lamb, ML
Tirado-Rives, J
Jorgensen, WL
Michejda, CJ
Ruby, SK
Smith, RH
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[3] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[4] Western Maryland Coll, Westminster, MD 21157 USA
来源
PROTEIN ENGINEERING | 2000年 / 13卷 / 06期
关键词
HIV-1; inhibitor; reverse transcriptase; mutation; modeling;
D O I
10.1093/protein/13.6.413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A computational model of the non-nucleoside inhibitor 8-Cl TIBO complexed with HIV-1 reverse transcriptase (RT) was constructed in order to determine the binding free energies. Using Monte Carlo simulations, both free energy perturbation and linear response calculations were carried out for the transformation of wild-type RT to two key mutants, Y181C and L100I. The newer linear response method estimates binding free energies based on changes in electrostatic and van der Waals energies and solvent-accessible surface areas. In addition, the change in stability of the protein between the folded and unfolded states was estimated for each of these mutations, which are known to emerge upon treatment with the inhibitor. Results from the calculations revealed that there is a large hydrophobic contribution to protein stability in the native, folded state. The calculated absolute free energies of binding from both the linear response, and also the more rigorous free energy perturbation method, gave excellent agreement with the experimental differences in activity. The success of the relatively rapid linear response method in predicting experimental activites holds promise for estimating the activity of the inhibitors not only against the wild-type RT, but also against key protein variants whose emergence undermines the efficacy of the drugs.
引用
收藏
页码:413 / 421
页数:9
相关论文
共 35 条
[21]  
MOERMANS M, 1995, 4 INT WORKSH HIV 1 D
[22]   ACCESSIBLE SURFACE-AREAS AS A MEASURE OF THE THERMODYNAMIC PARAMETERS OF HYDRATION OF PEPTIDES [J].
OOI, T ;
OOBATAKE, M ;
NEMETHY, G ;
SCHERAGA, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3086-3090
[23]   Computational binding studies of orthogonal cyclosporin-cyclophilin pairs [J].
Pierce, AC ;
Jorgensen, WL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1997, 36 (13-14) :1466-1469
[24]   CONTRIBUTION OF THE HYDROPHOBIC EFFECT TO PROTEIN STABILITY - ANALYSIS BASED ON SIMULATIONS OF THE ILE-96-]ALA MUTATION IN BARNASE [J].
PREVOST, M ;
WODAK, SJ ;
TIDOR, B ;
KARPLUS, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10880-10884
[25]   THE STRUCTURE OF UNLIGANDED REVERSE-TRANSCRIPTASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
RODGERS, DW ;
GAMBLIN, SJ ;
HARRIS, BA ;
RAY, S ;
CULP, JS ;
HELLMIG, B ;
WOOLF, DJ ;
DEBOUCK, C ;
HARRISON, SC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :1222-1226
[26]   MOLECULAR MODELING STUDIES OF HIV-1 REVERSE-TRANSCRIPTASE NONNUCLEOSIDE INHIBITORS - TOTAL-ENERGY OF COMPLEXATION AS A PREDICTOR OF DRUG PLACEMENT AND ACTIVITY [J].
SMITH, MBK ;
ROUZER, CA ;
TANEYHILL, LA ;
SMITH, NA ;
HUGHES, SH ;
BOYER, PL ;
JANSSEN, PAJ ;
MOEREELS, H ;
KOYMANS, L ;
ARNOLD, E ;
DING, JP ;
DAS, K ;
ZHANG, WY ;
MICHEJDA, CJ ;
SMITH, RH .
PROTEIN SCIENCE, 1995, 4 (10) :2203-2222
[27]   Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action [J].
Smith, MBK ;
Michejda, CJ ;
Hughes, SH ;
Boyer, PL ;
Janssen, PAJ ;
Andries, K ;
Buckheit, RW ;
Smith, RH .
PROTEIN ENGINEERING, 1997, 10 (12) :1379-1383
[28]   Structure and mechanism of action of nonnucleoside inhibitors of HIV-1 reverse transcriptase: strategies to combat drug resistance [J].
Smith, RH ;
Michejda, CJ ;
Hughes, SH ;
Arnold, E ;
Janssen, PAJ ;
Smith, MBK .
THEOCHEM-JOURNAL OF MOLECULAR STRUCTURE, 1998, 423 (1-2) :67-77
[29]   Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method [J].
Smith, RH ;
Jorgensen, WL ;
Tirado-Rives, J ;
Lamb, ML ;
Janssen, PAJ ;
Michejda, CJ ;
Smith, MBK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (26) :5272-5286
[30]   HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors [J].
Spence, RA ;
Anderson, KS ;
Johnson, KA .
BIOCHEMISTRY, 1996, 35 (03) :1054-1063